The US Food and Drug Administration for the third consecutive year includes OTC monograph user fees in its budget request, but in its fiscal year 2021 proposal the agency for the first time suggests extending its “Field Alert Reports” requirement to monograph OTCs.
The agency’s document submitted to Congress as justification for its FY 2021 budget request includes in its list of legislative initiatives proposing to require Field Alert Reports (FARs) for drug...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?